Integra Lifesciences Holdings Balance Sheet
IART / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 15 fiscal years. All figures from audited SEC 10-K filings.
Integra Lifesciences Holdings had $3.6B in total assets and $1.0B in shareholders' equity as of FY2025. Total debt was $727M against $235M in cash, resulting in $492M net debt.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $235.0M | $246.4M | $276.4M | $456.7M | $513.4M | $470.2M | $198.9M | $138.8M | $174.9M | $102.1M | $48.1M | $71.7M | $120.6M | $128.8M | $100.8M |
| Accounts Receivable | $278.8M | $272.4M | $259.3M | $263.5M | $231.8M | $225.5M | $275.3M | $265.7M | $251.8M | $148.2M | $132.2M | $110.4M | $118.1M | $114.9M | $118.1M |
| Inventory | $492.7M | $429.1M | $389.6M | $324.6M | $317.4M | $310.1M | $316.1M | $280.3M | $296.3M | $217.3M | $211.4M | $189.1M | $206.9M | $171.8M | $171.3M |
| Current Assets | $1.2B | $1.1B | $1.1B | $1.2B | $1.2B | $1.2B | $858.2M | $775.1M | $822.1M | $495.2M | $438.5M | $529.3M | $521.2M | $453.1M | $452.3M |
| PP&E (Net) | $444.3M | $405.7M | $340.2M | $311.3M | $311.7M | $287.5M | $337.4M | $300.1M | $269.3M | $222.4M | $205.2M | $193.6M | $200.3M | $177.9M | $131.4M |
| Goodwill | $615.2M | $1.1B | $1.1B | $1.0B | $1.0B | $932.4M | $954.3M | $926.5M | $937.9M | $510.6M | $512.4M | $363.5M | $249.8M | $294.1M | $293.0M |
| Total Assets | $3.6B | $4.0B | $3.8B | $3.9B | $3.8B | $3.6B | $3.3B | $3.1B | $3.2B | $1.8B | $1.8B | $1.6B | $1.2B | $1.2B | $1.1B |
| Current Liabilities | $456.0M | $922.1M | $307.0M | $320.9M | $340.0M | $401.0M | $331.3M | $262.6M | $348.9M | $123.6M | $139.1M | $126.0M | $119.4M | $106.9M | $101.9M |
| Total Debt | $726.6M | $760.5M | $775.0M | $775.0M | $843.8M | $877.5M | $877.5M | $900.0M | - | - | - | - | - | - | - |
| Shareholders' Equity | $1.0B | $1.5B | $1.6B | $1.8B | $1.7B | $1.5B | $1.4B | $1.4B | $962.3M | $839.7M | $751.4M | $704.3M | $666.1M | $500.0M | $492.6M |